Holen Sie sich die Stockscreener-App
1.49
3.25%
-0.05
Handel nachbörslich:
1.48
-0.01
-0.67%
Schlusskurs vom Vortag:
$1.54
Offen:
$1.57
24-Stunden-Volumen:
61,818
Relative Volume:
1.70
Marktkapitalisierung:
$69.73M
Einnahmen:
$8.98M
Nettoeinkommen (Verlust:
$-48.79M
KGV:
-1.8695
EPS:
-0.797
Netto-Cashflow:
$-36.77M
1W Leistung:
-6.29%
1M Leistung:
-9.15%
6M Leistung:
-40.40%
1J Leistung:
-43.56%
1-Tages-Spanne:
$1.45
$1.7226
1-Wochen-Bereich:
$1.45
$1.7226
52-Wochen-Spanne:
$1.45
$2.9319
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
1.49 | 72.07M | 8.98M | -48.79M | -36.77M | -0.797 |
ABT
Abbott Laboratories
|
102.30 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.30 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.19 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-02 | Eingeleitet | Maxim Group | Buy |
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
Published on: 2026-04-06 18:18:37 - baoquankhu1.vn
InspireMD, Inc. Enters Equity Distribution Agreement with BTIG, LLC – SEC 8-K Filing Details (April 2026) - Minichart
InspireMD Establishes New $75 Million ATM Program - TipRanks
According to the latest submitted documents, medical device company InspireMD Inc. has signed an equity distribution agreement with the sales agent. - Bitget
InspireMD Launches $75 Million At-The-Market Equity Program With BTIG - TradingView
InspireMD (NSPR) sets $75M BTIG equity distribution agreement - Stock Titan
InspireMD (NSPR) launches up to $75M ATM program with BTIG as agent - Stock Titan
NSPR Technical Analysis & Stock Price Forecast - Intellectia AI
InspireMD to Present at 25th Annual Needham Virtual Healthcare Conference - National Today
InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Stroke-device maker InspireMD will speak at Needham's April 14 webcast - Stock Titan
Stock Market Recap: Is InspireMD Inc stock risky to hold nowMarket Growth Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic - MSN
Published on: 2026-03-28 05:12:59 - baoquankhu1.vn
Market Trends: Will InspireMD Inc stock hit new highs in YEAR2026 Technical Overview & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
CEO Moves: Will InspireMD Inc stock hit new highs in YEAR2026 Sentiment & Proven Capital Preservation Methods - baoquankhu1.vn
InspireMD tops Q4 estimates as revenue jumps, shares rise in premarket trading - MSN
Geopolitics Watch: Can InspireMD Inc keep up with sector leadersMarket Risk Summary & Real-Time Market Sentiment Reports - baoquankhu1.vn
InspireMD Q2 2025 Earnings Preview - MSN
InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains US traction - MSN
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Johnson & Johnson (JNJ) and InspireMD (NSPR) - The Globe and Mail
InspireMD, Inc. (NSPR) reports Q4 loss, beats revenue estimates - MSN
InspireMD revenue up 62% to USD 3.1M in Q4 2025 - Medical Buyer
Returns Recap: Can InspireMD Inc outperform in the next rallyDay Trade & Safe Entry Trade Reports - baoquankhu1.vn
InspireMD Reports 62% Q4 Revenue Growth and Sets 2026 Outlook for CGuard Prime Carotid Stent System - Minichart
InspireMD’s Growth Hinges on Real CAS Market Size and Physician Adoption - TipRanks
Earnings call transcript: InspireMD Q4 2025: Revenue Surges, EPS Beats By Investing.com - za.investing.com
InspireMD earnings beat by $0.05, revenue topped estimates - Investing.com Canada
InspireMD, Inc. (NSPR) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
InspireMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: InspireMD Q4 2025: Revenue Surges, EPS Beats - Investing.com
InspireMD, Inc. Overview: CGuard Carotid Stent Technology, Business Strategy, and Market Leadership in Stroke Prevention 72 - Minichart
InspireMD Reports Strong Q4 2025 Growth and Expansion - TipRanks
FDA PMA and global expansion reshape InspireMD (NSPR) carotid focus - Stock Titan
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
InspireMD, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
InspireMD Q4 net income USD -11.761 million - marketscreener.com
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
INSPIREMD ($NSPR) Releases Q4 2025 Earnings - Quiver Quantitative
InspireMD (NSPR) revenue climbs 28% in 2025 as net loss widens - Stock Titan
InspireMD Q4 revenue rises 62%, beats estimates - TradingView
NSPR: Q4 2025 revenue surged 62% year-over-year, with 2026 revenue growth projected at up to 65% - TradingView
InspireMD, Inc. (NSPR) Announces Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
InspireMD Q4 2025 earnings preview - MSN
InspireMD, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener
InspireMD Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
921,587 Shares in InspireMD, Inc. $NSPR Purchased by Ghisallo Capital Management LLC - MarketBeat
Stock Recap: Is InspireMD Inc a momentum stockQuarterly Trade Report & Safe Capital Investment Plans - baoquankhu1.vn
Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR - MarketBeat
InspireMD (NSPR) price target increased by 25.00% to 5.10 - MSN
Aug Opening: Can InspireMD Inc outperform in the next rally2026 Analyst Calls & Low Drawdown Trading Techniques - baoquankhu1.vn
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):